|Articles|July 28, 2020

Delays in Covid-19 Testing and Tracing Affect Transmission Rate

A new modeling study reveals that transmission rates decline if people get their results early and quickly notify contacts of potential exposure.

When communities decide to begin opening up after being locked down due to the novel coronavirus, it’s imperative to have in place an efficient testing and tracing strategy so nascent outbreaks can be stopped. Central to this strategy is speed--the ability to access test results quickly as well as swiftly notify personal contacts who may be at risk.

The faster people who test positive or who are identified as contacts of people who test positive are able to isolate themselves, the less likely the infection will be passed around.

A team of Dutch researchers designed a mathematical modeling study highlighting the impacts of delays at various points in the testing and tracing process. The study, published in The Lancet, assumes an optimal scenario in which subjects first experience symptoms, then get tested and receive results that same day (zero delays).

This best-case scenario assumes that 80% of people who need a test can get tested and that 80% of subjects’ contacts can be traced. In this scenario, the reproduction number of 1.2, which means an average subject would likely pass the infection on to 1.2 people, drops to 0.8.

The investigators found that time is of the essence when it comes to testing and tracing, which ideally work in tandem. When 4 out of 5 symptomatic people are tested and self-isolate within 1 day of symptoms appearing, the reproduction number should drop from 1.2 to 1.0. Quick contract tracing can further lower that number to 0.8.

However, if there is a 2-day delay in testing and isolating, contract tracing must be done within a day--or at least 80% of contacts must be reached--to ensure that the reproduction number does not slip above 1.0. If there is a 3-day delay between the development of symptoms and test results, the chances of keeping the reproduction number below 1.0 are minimal.

“If testing takes [too] long and tracing only starts several days after symptom onset of the index case, the infected contact persons will only be found when they have already caused new infections,” Mirjam Kretzschmar, PhD, a professor of epidemiology at the Julius Center for Health Sciences and Primary Care at the University of Utrecht and the lead author of the study, told Contagion®. “Reducing delays in tracing is also important, but if the time between symptom onset of the index [patient] and start of tracing is too long, the tracing is too late to prevent the contact persons from transmitting to others.”

To boost the efficacy of contact tracing, Kretzschmar and her team suggest employing mobile technology. Traditional contract tracing relies on a team of workers gathering data on an infected person’s contacts and then calling them; much faster is text-based messaging that can be deployed instantly.

In the study, the authors assert that the reproduction rate will stay above 1.0 if conventional contact tracing is delayed by 1 day or more, while app-based tracing will lower the reproduction rate below 1.0 even if tracing is delayed by a couple of days. They also note that even with just 20% of contacts traced, app-based tracing can lower the reproduction rate by 17.6% vs. 2.5% with conventional tracing.

“Digital tracing will be more effective the more people use it,” says Kretzschmar. “The main advantage is that time can be saved, but there [are] still other questions to be solved.” These questions include whether people will sign up to be in a contact database, given privacy concerns, and whether people who are less comfortable with technology--perhaps senior citizens—will make use of it.

No matter the methods used, though, for Kretzschmar the goal remains clear: “The main message is that testing is important. Test results and tracing should be very fast for contract tracing to contribute to control of Covid-19.”


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.